Cempra Pharmaceuticals

Concerns at Wockhardt, Hospira plants factor into CRL issued to Cempra

FDA concerns with manufacturing by India’s Wockhardt and Pfizer’s Hospira are one of the factors to derail the approval of a new antibiotic being developed by a U.S. biotech.

Eric Palmer Jan 2, 2017 10:11pm

Wockhardt problems could delay approval of Cempra's antibiotic

Nov 1, 2016 9:36am